eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes is a research paper published in Diabetologia (2024). On theSindex it has a DataRank of 0.292. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Heart, Lung, and Blood Institute
Grant: HL126609
National Heart, Lung, and Blood Institute
Grant: HL141387
National Heart, Lung, and Blood Institute
Grant: HL142214
National Heart, Lung, and Blood Institute
Grant: HL146764
Congressionally Directed Medical Research Programs
Grant: W81XWH2110472
NHLBI NIH HHS
Grant: P01 HL126609
NHLBI NIH HHS
Grant: R01 HL141387
NHLBI NIH HHS
Grant: R01 HL142214
NHLBI NIH HHS
Grant: R01 HL146764
National Institutes of Health
Grant: 2UL1TR001442-06
UC San Diego Clinical and Translational Research Institute
National Institutes of Health
Grant: 5R01HL146764-02
Role of Gap Junction in Hypoxia-induced Pulmonary Hypertension
National Institutes of Health
Grant: 1S10OD032268-01
VEVO 3100 + LAXR-X Acoustic Imaging System
National Institutes of Health
Grant: 1S10OD026929-01
Illumina NovaSeq 6000 Sequencing System
FWCI
1.57
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals